Literature DB >> 1325470

Isolation of a cell line for rapid and sensitive histochemical assay for the detection of herpes simplex virus.

E C Stabell1, P D Olivo.   

Abstract

A cell line which can be used in a simple, sensitive, and rapid histochemical assay was isolated for detection of herpes simplex virus (HSV). The cell line was derived by selection of G418 resistant colonies following co-transfection of baby hamster kidney cells with a plasmid which contains a G418 antibiotic resistance marker and a plasmid which contains the Escherichia coli LacZ gene placed behind an inducible HSV promoter. The promoter is from HSV-1UL39 which encodes ICP6, the large subunit of ribonucleotide reductase (RR1). This promoter has a number of features which make it ideal for the detection of HSV. First, there is no constitutive expression from this promoter in uninfected cells. Second, activation of the promoter appears to be specific for HSV. Third, expression from this promoter occurs within hours after infection. Fourth, this promoter is strongly transactivated by the virion associated trans-activator protein VP16. As early as six hours after infection HSV-infected cells can be detected by histochemical staining for beta-galactosidase activity. Infected cells stain intensely blue whereas uninfected cells show no staining, and a single infected cell can easily be recognized in a microscopic field of uninfected cells. Both HSV-1 and HSV-2 are detected with this cell line, but after infection with human cytomegalovirus (HCMV), varicella zoster virus (VZV), adenovirus, and sindbis virus no blue cells were detected. Quantitation of HSV-1 stocks on this cell line by counting blue cell forming units (BFU) reveals that the number of BFU/ml closely approximates the number of plaque forming units (PFU)/ml as determined by plaque assays on the parent cell line. This cell line should provide a useful adjunct in the diagnostic virology laboratory for the rapid detection of HSV in clinical specimens.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1325470     DOI: 10.1016/0166-0934(92)90110-y

Source DB:  PubMed          Journal:  J Virol Methods        ISSN: 0166-0934            Impact factor:   2.014


  20 in total

1.  Confirmation of low-titer, herpes simplex virus-positive specimen results by the enzyme-linked virus-inducible system (ELVIS) using PCR and repeat testing.

Authors:  N Patel; L Kauffmann; G Baniewicz; M Forman; M Evans; D Scholl
Journal:  J Clin Microbiol       Date:  1999-12       Impact factor: 5.948

2.  ELVIRA HSV, a yield reduction assay for rapid herpes simplex virus susceptibility testing.

Authors:  Ruzena Stránská; Rob Schuurman; David R Scholl; Joseph A Jollick; Carl J Shaw; Caroline Loef; Merjo Polman; Anton M van Loon
Journal:  Antimicrob Agents Chemother       Date:  2004-06       Impact factor: 5.191

3.  IFN-gamma action in the media of the great elastic arteries, a novel immunoprivileged site.

Authors:  A J Dal Canto; P E Swanson; A K O'Guin; S H Speck; H W Virgin
Journal:  J Clin Invest       Date:  2001-01       Impact factor: 14.808

Review 4.  Role of cell culture for virus detection in the age of technology.

Authors:  Diane S Leland; Christine C Ginocchio
Journal:  Clin Microbiol Rev       Date:  2007-01       Impact factor: 26.132

Review 5.  Transgenic cell lines for detection of animal viruses.

Authors:  P D Olivo
Journal:  Clin Microbiol Rev       Date:  1996-07       Impact factor: 26.132

6.  Antiviral susceptibility testing with a cell line which expresses beta-galactosidase after infection with herpes simplex virus.

Authors:  P Tebas; E C Stabell; P D Olivo
Journal:  Antimicrob Agents Chemother       Date:  1995-06       Impact factor: 5.191

7.  Evaluation of a genetically engineered cell line and a histochemical beta-galactosidase assay to detect herpes simplex virus in clinical specimens.

Authors:  E C Stabell; S R O'Rourke; G A Storch; P D Olivo
Journal:  J Clin Microbiol       Date:  1993-10       Impact factor: 5.948

8.  Herpes simplex virus type 2 UL24 gene is a virulence determinant in murine and guinea pig disease models.

Authors:  Susan Blakeney; Jacek Kowalski; Donna Tummolo; Joanne DeStefano; David Cooper; Min Guo; Seema Gangolli; Deborah Long; Timothy Zamb; Robert J Natuk; Robert J Visalli
Journal:  J Virol       Date:  2005-08       Impact factor: 5.103

9.  Cervicovaginal neutralizing antibodies to herpes simplex virus (HSV) in women seropositive for HSV Types 1 and 2.

Authors:  Francois-Xavier Mbopi-Kéou; Laurent Bélec; Julie Dalessio; Jérôme Legoff; Gérard Grésenguet; Philippe Mayaud; David W G Brown; Rhoda Ashley Morrow
Journal:  Clin Diagn Lab Immunol       Date:  2003-05

10.  Regulated expression of a Sindbis virus replicon by herpesvirus promoters.

Authors:  L Ivanova; S Schlesinger; P D Olivo
Journal:  J Virol       Date:  1999-03       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.